Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
08/2003
08/14/2003WO2003066103A1 Pharmaceutical compositions for hepatitis c viral protease inhibitors
08/14/2003WO2003066102A1 Immunocytokine-containing lyophilized preparation
08/14/2003WO2003066101A1 Preparation for oxidation-sensitive compounds and method for making same
08/14/2003WO2003066085A1 Albumin-fused anti-angiogenesis peptides
08/14/2003WO2003066083A1 Preparations for treating bone fracture or bone loss or elevating bone density
08/14/2003WO2003066078A1 Hiv inhibiting proteins
08/14/2003WO2003066073A2 Compositions containing oat straw and willowherb extract
08/14/2003WO2003066068A1 Hpma-polyamine conjugates and uses therefore
08/14/2003WO2003066063A1 Pharmaceutical compositions comprising 17alpha-furanylesters of 17beta-carbothioate androstanes with a muscarinic receptor antagonist
08/14/2003WO2003066058A1 Pharmaceutical composition for regeneration of cirrhotic liver
08/14/2003WO2003066042A1 A non-arrhythmogenic metabolite of oxybutynin
08/14/2003WO2003066036A1 Pharmaceutical formulation for administration by inhalation comprising an androstane derivative and a beta-2-adrenoreceptor for the treatment of inflammatory and allergic conditions
08/14/2003WO2003066033A1 Formulation for inhalation comprising a glucocorticoid and a beta 2-adrenoreceptor agonist
08/14/2003WO2003066032A1 Formulations for inhalation
08/14/2003WO2003066031A1 Cyclodextrines for use as suspension stabilizers in pressure-liquefied propellants
08/14/2003WO2003066030A2 Pharmaceutical tablet
08/14/2003WO2003066029A2 Pharmaceutical dosage form for mucosal delivery
08/14/2003WO2003066028A1 Manufacture of oral dosage forms delivering both immediate-release and sustained-release drugs
08/14/2003WO2003066027A1 Sterile lyophilized ifosfamide and associated methods
08/14/2003WO2003066026A1 Pharmaceutical formulation comprising an androstane derivative and a solubilising agent in an aqueous liquid carrier
08/14/2003WO2003066025A1 Clear micellized formulations of beta-carotene for treating leukoplakia
08/14/2003WO2003066024A1 Pharmaceutical formulation comprising an aqueous suspension of an androstane derivative for the treatment of inflammatory and allergic conditions
08/14/2003WO2003066023A1 A stable pharmaceutical formulation comprising torsemide modification ii
08/14/2003WO2003066022A2 Stable pharmaceutical composition useful for treating gastrointestinal disorders
08/14/2003WO2003066021A2 Drug nanoparticles with lysozyme surface stabiliser
08/14/2003WO2003066020A1 Composition for easing human childbirth
08/14/2003WO2003066019A2 Method for producing water dispersible dry powders from poorly soluble compounds
08/14/2003WO2003066012A1 Preparations containing diol
08/14/2003WO2003066001A2 Zinc salt compositions for the prevention of mucosal irritation from spermicides and microbicides
08/14/2003WO2003066000A2 Formulation comprising bioactive agents and method of using same
08/14/2003WO2003065993A2 Primary rat hepatocyte toxicity modeling
08/14/2003WO2003065980A2 Methods and formulations for eradicating or alleviating staphylococcal nasal colonization using lysostaphin
08/14/2003WO2003065928A2 Therapeutic polyesters and polyamides
08/14/2003WO2003065924A1 Control of a biological function
08/14/2003WO2003065806A1 New immunoeffector compounds
08/14/2003WO2003049559A3 Method of producing a nicotine composition
08/14/2003WO2003045437A8 Pharmaceutical compositions of 5,7,14-triazatetracyclo[10.3.1.0(2,11).0(4,9)]-hexadeca-2(11)3,5,7,9-pentaene
08/14/2003WO2003045331A3 Formulations for oral administration of cromolyn sodium
08/14/2003WO2003043586A3 Compositions for sustained action product delivery
08/14/2003WO2003035237A3 Compounds for use as surfactants
08/14/2003WO2003035177A3 Optimal polymer mixtures for gastric retentive tablets
08/14/2003WO2003030935A3 Adjuvants for nucleic acid vaccines
08/14/2003WO2003028618A3 Systems, methods and apparatuses for manufacturing dosage forms
08/14/2003WO2003026733A3 Microneedle with membrane
08/14/2003WO2003015699A3 Topical compositions and methods for treating pain
08/14/2003WO2003015661A3 Treatment patch
08/14/2003WO2003000202A3 Particles for inhalation having rapid release properties
08/14/2003WO2002096374A3 Dermatological compositions and methods comprising alpha-hydroxy acids or derivatives
08/14/2003WO2002058703A3 The treatment of sexual dysfunction and cardiovascular disease with quinolinone enantiomers
08/14/2003WO2002045618A3 Oral capsule for administering tablets to animals
08/14/2003WO2002041840A3 Sildenafil citrate chewing gum formulations and methods of using the same
08/14/2003WO2002028420A3 Regulation of cell proliferation and differentiation using topically applied nucleic acid molecules
08/14/2003US20030153964 Polymerizable material and sheet material derived therefrom
08/14/2003US20030153724 Lactic acid polymer and process for producing the same
08/14/2003US20030153629 Suppressing biosynthesis of exotoxins using terpenes selected from terpineol, beta-ionone, terpin, linalool, geraniol or menthol, and etherified polyoxyalkylene glycols
08/14/2003US20030153626 Administering antiestrogens, adenosine receptor and calmodulin antagonists for prophylaxis of vision defects
08/14/2003US20030153623 Solid preparation containing sparingly soluble NSAIDs
08/14/2003US20030153622 Ophthalmic solution and contact lens solution
08/14/2003US20030153618 Treatment and prevention of herpes simplex infections
08/14/2003US20030153617 Anticholesterol agent tablets having a pH within the range of 5.0 to 7.5, based on a 20 wt % aqueous slurry; storage stability
08/14/2003US20030153614 Method for preparing and using polyoxyethylated castor oil in pharmaceutical compositions
08/14/2003US20030153613 Hypotensive agents for eye, using an aclurea indole compounds, potassium channel blockers; glaucoma
08/14/2003US20030153608 Torasemide-containing pharmaceutical preparations
08/14/2003US20030153607 Novel composition and use
08/14/2003US20030153592 Method
08/14/2003US20030153590 Method of treating alcoholism or alcohol abuse
08/14/2003US20030153585 Comprises low water soluble 4-(4-(3-chloro-4-methoxybenzyl-amino)-benzo(4,5)thieno(2,3-d)pyrimidin-2 -yllcyclohexane-carboxylic acid; improved oral administration, bioavailability
08/14/2003US20030153543 Novel anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use
08/14/2003US20030153541 Liver X receptor modulator comprising an oxysterol, lipid regulating HMG-CoA reductase inhibitor, fibric acid derivative, niacin, bile-acid sequestrant, probucol, raloxifene, unsaturated omega-3 fatty acid
08/14/2003US20030153539 Use of estramustine phosphate or a metabolite thereof in preparation of anticarcinogenic agent
08/14/2003US20030153530 Solubility enhancing component other than a cyclodextrin, particularly a polyanionic component, an oxy-chloro component to aid in preserving the composition, liquid carrier
08/14/2003US20030153529 Dextrin containing compositions for prevention of adhesions
08/14/2003US20030153526 Compositions contain antisense oligonucleotides that hybridize to Grb2 and Crkl nucleic acids, gene products of which are known to interact with tumorigenic protein bcr-abl
08/14/2003US20030153516 Methods and materials for treating and preventing inflammation of mucosal tissue
08/14/2003US20030153475 Soaking contact lens in aqueous composition that comprises tromethamine in amount effective to reduce amount of denatured protein on lens
08/14/2003US20030153081 Viral core protein-cationic lipid-nucleic acid-delivery complexes
08/14/2003US20030152651 Herbal composition for angina pectoris, method to prepare same and uses thereof
08/14/2003US20030152650 Pharmaceutical composition for prevention and treatment of premature ejaculation and/or hypersensitivity of sexual stimulation
08/14/2003US20030152645 Aqueous ionic solutions and their uses in particular in ophthlamology
08/14/2003US20030152642 Mixture of chondroitin sulfate, glucosamine and hyaluronic acid
08/14/2003US20030152638 Injectable opioid partial agonist or opioid antagonist microparticle compositions and their use in reducing consumption of abused substances
08/14/2003US20030152637 Administering by injection; glycolic acid-lactic acid copolymer; sustained release particles
08/14/2003US20030152636 Method of treating cancer
08/14/2003US20030152635 Lipid nanocapsules, preparation process and use as medicine
08/14/2003US20030152634 Sustained release drugs, foods, plant safening agents
08/14/2003US20030152629 Multi component controlled release system for oral care, food products, nutracetical, and beverages
08/14/2003US20030152628 Dual release formulation comprising levodopa ethyl ester and a decarboxylase inhibitor in an immediate-release layer with levodopa ethyl ester in a controlled release core
08/14/2003US20030152627 Multi-particulate form of medicament, comprising at least two differently coated forms of pellet
08/14/2003US20030152626 Substance P antagonist; antidepressants; central nervous system disorders; respiratory system disorders
08/14/2003US20030152625 Ring-shaped devices
08/14/2003US20030152624 Controlled release dosage form having improved drug release properties
08/14/2003US20030152623 Sustained release; immobilization
08/14/2003US20030152622 Formulation of an erodible, gastric retentive oral diuretic
08/14/2003US20030152621 Pharmaceutical formulation of gepirone for oral administration
08/14/2003US20030152620 Tablet formulations comprising valsartan
08/14/2003US20030152619 Method and apparatus for blowmoding capsules of polyvinylalcohol and blowmolded polyvinylalcohol capsules
08/14/2003US20030152618 Immobilized unto polyoxyethylene glycol
08/14/2003US20030152617 Capsule, tablet with enteric, protective coatings; bioavailability
08/14/2003US20030152616 Rosin ester as crystal growth inhibitor
08/14/2003US20030152615 Enhanced drug delivery in transdermal systems
1 ... 2105 2106 2107 2108 2109 2110 2111 2112 2113 2114 2115 2116 2117 2118 2119 2120 2121 2122 2123 2124 2125 ... 2991